-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Prostate cancer is one of the most common malignant tumors of the male urinary system.
SPOP gene mutations may be related to prostate cancer treatment resistance.
For many years, the Multidisciplinary Urology and Oncology (MDT) team of Fudan University Cancer Hospital, led by the chief expert Professor Ye Dingwei, has addressed the "three dilemmas" of the low early diagnosis rate of Chinese prostate cancer, the low late survival rate and the lack of effective precision treatment models.